The use of octagam and gammanorm in immunodeficiency associated with hematological malignancies: a prospective study from 21 French hematology departments.
Omar BenbrahimJean-François ViallardSylvain ChoquetBruno RoyerFrédéric BauduerOlivier DecauxJean-Charles CraveYann FardiniPierre ClersonVincent LévyPublished in: Hematology (Amsterdam, Netherlands) (2018)
Our data confirm the efficacy of IgRT in reducing the risk of infections in HM-associated SID therefore fulfilling physicians' main expectations. They also illustrate the heterogeneity of management policies within the community setting.